A groundbreaking new study has revealed that depression experienced in both midlife and later life is associated with an increased risk of developing dementia. Published in eClinicalMedicine, the research provides some of the most robust evidence that mental health across the lifespan plays a crucial role in determining cognitive outcomes in older age. This study deepens our understanding of the temporal relationship between depression and dementia, helping to clarify whether the age at which depression first appears affects the likelihood of developing cognitive decline.
Jacob Brain and Maha Alshahrani led the research in collaboration between the Institute of Mental Health and the School of Medicine at the University of Nottingham, the University of Adelaide, and the Dementia Centre of Excellence at Curtin University in Australia. Speaking on the findings, Mr Brain stated, “Our study shows that depression is linked to an increased risk of dementia in both midlife and late life. This highlights the importance of recognising and treating depression across the life course, not just for mental health, but also as part of a broader strategy to protect brain health.” He also emphasised the need for public health initiatives to emphasise preventative mental healthcare as a key component of brain health promotion.
Globally, over 57 million people are currently living with dementia, and the number continues to rise as populations age. With no known cure, prevention has become a critical focus of public health. The identification of modifiable risk factors—like depression—has therefore gained prominence in research and policy. Understanding how, when, and why depression might contribute to the onset of dementia could open up new avenues for intervention, especially at earlier stages of life. However, prior research has been inconclusive about whether depression at specific life stages—midlife versus later life—has differential effects on dementia risk.
To address this, the research team conducted an umbrella review, which synthesised findings from existing systematic reviews and meta-analyses, ensuring that only the highest-quality evidence was included. They then went further by reanalysing data from the individual studies that those reviews were based on and adding more recent research that had been excluded from earlier analyses. This approach allowed for a comprehensive, up-to-date assessment of how depression at different life stages is linked to dementia risk, offering far greater specificity than earlier studies.
Their results were striking. Depression in both midlife (typically in one’s 40s or 50s) and late life (from one’s 60s onwards) was found to be significantly associated with a higher likelihood of developing dementia. By separating the analysis according to the timing of depression onset, the study reinforced the overall risk relationship and identified essential differences in how that risk manifests over time. Mr Brain noted that this clarity “helps guide future research, treatment, and prevention strategies” by identifying precisely when interventions could be most effective.
The study also raises the possibility that late-life depression may not only be a risk factor but could, in some cases, serve as an early indicator of dementia. The symptoms of depression and the early stages of cognitive decline can sometimes overlap, making it challenging to distinguish between the two. Nonetheless, by identifying patterns and timing, the researchers offer an essential step towards disentangling these relationships. If late-life depression indeed reflects early neurodegenerative changes, it might serve as a crucial window for early detection and intervention, even before more definitive symptoms of dementia appear.
While the biological mechanisms underlying the depression–dementia link remain complex, the study discusses several plausible pathways. These include chronic inflammation, hypothalamic-pituitary-adrenal (HPA) axis disruptions, vascular damage, neurotrophic factor changes, and neurotransmitter imbalances. There may also be genetic susceptibilities and behavioural factors, such as reduced physical activity or poor sleep, that contribute to the observed associations. Regardless of the exact mechanisms, this research reinforces the need to treat depression not only as a mental health condition but as a potential harbinger of future cognitive decline. In doing so, it calls for integrated mental and brain health strategies that prioritise early diagnosis, sustained support, and equitable access to effective treatment across all ages.
More information: Jacob Brain et al, Temporal dynamics in the association between depression and dementia: an umbrella review and meta-analysis, EClinicalMedicine. DOI: 10.1016/j.eclinm.2025.103266
Journal information: EClinicalMedicine Provided by University of Nottingham
